©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Medial ulnar collateral ligament reconstruction of the elbow in major league baseball players: Where do we stand?
Brandon J Erickson, Bernard R Bach Jr, Charles A Bush-Joseph, Nikhil N Verma, Anthony A Romeo, Midwest Orthopaedics at Rush, Rush University Medical Center, Chicago, IL 60611, United States
Author contributions: Erickson BJ, Bach Jr BR, Bush-Joseph CA, Verma NN and Romeo AA designed this study, wrote and edited the manuscript.
Conflict-of-interest statement: No author has any conflicts of interest that pertain to the submitted article. Other conflicts of interest are listed in the document of conflict-of-interest statement.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Brandon J Erickson, MD, Midwest Orthopaedics at Rush, Rush University Medical Center, 1611 W Harrison St, Suite 300, Chicago, IL 60611, United States. email@example.com
Telephone: +1-732-4925775 Fax: +1-312-9422040
Received: January 25, 2016
Peer-review started: January 25, 2016
First decision: February 29, 2016
Revised: March 8, 2016
Accepted: March 24, 2016
Article in press: March 25, 2016
Published online: June 18, 2016
The ulnar collateral ligament (UCL) is one of the most important structures about the elbow in the overhead athlete, especially the baseball pitcher[1,2]. While the UCL is not commonly stressed during activities of daily living, the baseball pitch imparts a significant amount of stress on the UCL, specifically the posterior band of the anterior bundle as it is this part of the UCL that sees the most stress at higher degrees of elbow flexion, causing the UCL to approach failure with each pitch[3-5]. Without the secondary osseous and soft tissue restraints about the elbow, the UCL would fail after each pitch as the valgus force generated at the elbow with each pitch is approximately 64 nmol/L, while the ultimate load to failure of the native and reconstructed UCL is 34.29 nmol/L, and 30.55 nmol/L, respectively.
Diagnosis of UCL tears is accomplished through patient history, physical exam maneuvers, and diagnostic imaging. Baseball pitchers who sustain tears to the UCL often report a decrease in velocity as well as a loss of accuracy in the time leading up to their injury. Some patients will have concomitant ulnar nerve symptoms, such as numbness/tingling of the pinky and ulnar half of the ring finger, weakness of the first dorsal interosseous muscle, and others. On physical exam, these patients can have pain along the course of the UCL. They may also have an increase in elbow valgus laxity compared to the contralateral arm, although this can be physiologic in baseball pitchers. Special physical exam maneuvers, including the moving valgus stress test and milking maneuver, are often positive in these patients as these tests stress the UCL in the position of throwing[6,9,10]. Although anteroposterior, lateral, and external oblique radiographs are useful to rule out calcifications in the UCL as well as other pathology, magnetic resonance imaging (MRI) with or without arthrography is the current imaging modality of choice to diagnose a UCL tear[11,12]. It seems that the increase in diagnosis of UCL tears is likely secondary to sports specialization in adolescents leading to an increase in the true number of UCL tears rather than an overdiagnosis on MRI like has been shown with superior labral tears[13-15].
Should the UCL fail, the current gold standard treatment option for elite level overhead athletes who wish to return to sport (RTS) at a high level after failing non-operative management is an UCL reconstruction (UCLR). Although repair of the UCL has been described with encouraging results for properly indicated adolescents, the results of repair have reproducibly been inferior to UCLR in major league baseball (MLB) athletes, and so UCLR has become to standard of care[7,16,17]. UCLR was initially described by Jobe et al in the literature in 1986, although the index surgery was performed on September 25, 1974 on then Los Angeles Dodgers pitcher, Tommy John.
The initial technique by Jobe et al called for an elevation of the flexor pronator mass with a submuscular transposition of the ulnar nerve and a figure of eight graft configuration in which the graft was sutured to itself. Results of the initial Jobe technique demonstrated that greater than 60% of elite throwing athletes were able to RTS at their pre-surgical level of participation. However, 21% of these patients had a post-operative ulnar neuropraxia, all of which resolved by seven years. Following this initial description, concern arose over the treatment of the flexor pronator mass, as well as the routine submuscular transposition of the ulnar nerve. Therefore, since the initial description by Dr. Jobe, many modifications have been made to improve patient outcomes and decrease complications following UCLR; these modifications include a split in the flexor pronator mass, subcutaneous ulnar nerve transposition, and varying ways to secure the graft both on the ulna as well as humerus[7,19-24].
EPIDEMIOLOGY OF UCLR IN MLB
Several studies have shown a recent increase in the number of UCL tears, and more specifically, the number of UCLR in MLB pitchers[2,25-27]. Recent studies have also shown an increase in the number of UCLR performed in adolescent athletes, specifically those between the ages of 15-19 years. When evaluating MLB players, as expected, UCLR is significantly more common in MLB pitchers than any other position. When Conte et al surveyed 5088 professional baseball players, there was a 16% prevalence of UCLR amongst pitchers compared to only 3% amongst all other position players. Interestingly, this survey study by Conte et al found that 25% of al MLB pitchers admitted to a history of UCLR, while 15% of minor league pitchers had undergone UCLR. No difference was seen in the prevalence of UCLR between pitchers born in the United States vs those born in Latin America countries. Erickson et al[25,26] showed a significant increase in the number of UCLR in MLB pitchers from 2000 to 2012 (P = 0.014), and further studies have demonstrated that the number has continued to rise in 2013 and 2014. Interestingly, there was no statistically significant increase in the number of UCLR in MLB pitchers between the 1980s and 1990s. MLB pitchers who underwent primary UCLR played an average of 5.27 ± 4.34 seasons prior to surgery. Furthermore, pitchers who grew up in warm weather climates were more likely to undergo UCLR earlier in their MLB career than those from cold weather climates. While the increase in UCLR has been clearly documented, the reason for this increase remains unknown. There have been no prospective studies in the literature to date that have definitively shown what the cause of this increase in the number of UCLR is.
Several studies have, however, demonstrated risk factors for elbow injuries in adolescent athletes including pitching more than 100 innings per year, high pitch counts, pitching on consecutive days, pitching for multiple teams, pitching while fatigued, pitching year round, pitching with higher velocity, pitching with supraspinatus weakness, geography, pitching with a glenohumeral internal rotation deficit, and most recently pitching with a loss of total arc of motion, especially decreased external rotation[26,29-38]. While these risk factors have been well established, there have been no studies to date that have been able to show a risk reduction in the number of UCLR by implementing programs to limit these risk factors. This is an area that requires further attention in the coming years as there does not appear to be an end in sight to the growing number of UCLR, and injury prevention must be at the forefront of current research to protect both MLB and adolescent pitchers.
Although the increase in the number of primary UCLR in MLB pitchers is worrisome, a more pressing concern is the increase in the number of revision UCLR in these athletes[2,40-42]. Wilson et al evaluated 271 professional baseball pitchers who underwent primary UCLR and found that 40 (15%) required at least one revision UCLR during their pitching career while three pitchers required a second revision. The revision surgery occurred an average of 5.2 ± 3.2 years following the index UCLR, although there was a wide range from 1-13 years. As pitchers are beginning to undergo UCLR at earlier ages, it begs the question if the longevity of these athletes is going to decrease with time. Some would argue that a pitcher has a finite number of innings he can throw. If adolescent athletes are throwing year round and not following the rules set forth for their protection regarding inning and pitch count limits, these athletes could begin to undergo their index UCLR at earlier ages, causing the likelihood of a revision UCLR to rise, thereby limiting the ultimate number of years they can pitch in MLB.
OUTCOMES FOLLOWING PRIMARY AND REVISION UCLR IN MLB PITCHERS
There have been many studies that have looked at publically available data to determine the outcomes following UCLR in MLB pitchers as it relates to RTS as well as overall performance upon RTS[25,43]. Erickson et al evaluated all MLB pitchers from 1974 to 2012 who underwent UCLR using publically available data, team injury reports, etc., and compared this group to a matched control group of healthy MLB pitchers. The authors found a total of 179 pitchers who underwent UCLR having pitched at least one game in MLB. Of these 179 pitchers, 148 (83%) were able to RTS and pitch in at least one MLB game following UCLR, 174 (97.2%) were able to RTS in either the major or minor leagues, and only 5 pitchers (2.8%) were unable to pitch again in the major or minor leagues. The pitchers were able to RTS at an average of 20.5 ± 9.72 mo following their UCLR and pitched for an average of 3.9 ± 2.84 years after their RTS. The number of years pitched after RTS may have been falsely low as 56 of these pitchers were still active in MLB at the time the study was conducted.
When the authors evaluated the performance of these MLB pitchers upon RTS they found that pitchers pitched fewer innings in season following their UCLR and had fewer wins and losses per season compared to before surgery. Furthermore, pitchers had a significantly lower earned run average (ERA) and walks plus hits per inning pitched (WHIP) following surgery than beforehand. WHIP is a sabermetric that is calculated by summing a pitcher’s total walks and hits for one season and dividing the sum by the number of innings pitched that season. A later study conducted by Jiang et al evaluated 28 MLB pitchers between 2008-2010 who underwent UCLR to determine if pitching velocity, as well as performance variables changed compared both to pre-operative levels upon RTS in MLB as well as control group of healthy MLB pitchers. The authors found a statistically significant decrease in mean pitch velocity of both the fastball and changeup in each post-injury year compared to pre-injury velocities. The average decrease in fastball velocity for post-UCLR years 1-3 was 1.3, 1.0, 1.0 miles per hour (mph) respectively. The average decrease in changeup velocity for post-UCLR years 1-3 was 1.2, 1.3, 1.0 mph respectively. Furthermore, a decrease in curveball velocity was seen in post UCLR years 2 and 3 that averaged 1.0 and 1.7 mph respectively. However, despite these differences between pre and post UCLR pitching velocities in the group of pitchers who underwent UCLR, there was no significant difference in mean pitch velocity for any pitch, in any year following UCLR in cases vs matched controls. Hence, this could mean that pitchers who sustain UCL tears and undergo UCLR are throwing faster than their peers at baseline. Lansdown et al performed a similar study and found similar results; pitchers who underwent UCLR had a significant decrease in mean fastball velocity (91.3 mph vs 90.6 mph) (P = 0.003), with the greatest decrease in velocity seen in pitchers older than 35 years of age (91.7 to 88.8 mph) (P = 0.0048). Despite the belief from players, parents, and coaches as shown by Ahmad et al that UCLR will improve a pitchers velocity, these two studies clearly demonstrate a small but significant decrease in velocity following UCLR.
While the results following primary UCLR in MLB pitchers are reliable, the results following revision UCLR in the same patient population are not as encouraging. Marshall et al evaluated 33 MLB pitchers who underwent revision UCLR and compared these pitchers to matched controls to determine if differences existed in performance upon RTS. The authors found that 65.5% of pitchers who underwent revision UCLR were able to return to RTS in MLB while 84.8% were able to RTS in either the major or minor leagues; both rates are lower than RTS rates following index UCLR of 83% for MLB and 97.2% for either major or minor leagues. Interestingly, when Liu et al also evaluated 31 MLB pitchers following revision UCLR surgery, the authors found that while 65% were able to RTS in the MLB for one game or more, only 42.8% were able to pitch 10 or more games in MLB. Similar to the reported length of recovery following primary UCLR of 20.5 mo, the average time to RTS following revision UCLR was 20.76 mo[25,46].
When compared to pre-injury performance levels, following revision UCLR pitchers pitched fewer innings, had fewer wins and losses, and let up more walks per nine innings. The only performance parameter that improved was the number of runs allowed per nine innings declined following revision surgery. Furthermore, pitchers who were able to RTS following revision UCLR pitched significantly fewer seasons than matched controls (2.6 vs 4.9 seasons). Following revision UCLR, pitchers had no difference in ERA and WHIP when compared to controls. Unfortunately, following revision UCLR pitchers threw significantly fewer innings, gave up significantly more walks, and had significantly fewer wins (although they also had significantly fewer losses) compared to controls.
Although there have bee numerous studies that have reported on the RTS rate and outcomes of MLB pitchers following both primary and revision UCLR, there have been no prospective studies in this athlete cohort that have evaluated RTS rate or success upon RTS as it relates to surgical technique, graft choice, management of the ulnar nerve, concomitant arthroscopy, rehabilitation protocol, and timing of RTS[25,40,44,46]. In order to improve outcomes, it is necessary to determine if these variables influence outcomes in MLB pitchers. One topic that has received recent attention is when to allow pitchers to throw for the first time following UCLR. While some protocols wait five months or more, some allow throwing as early as three to four months. Unfortunately, no data exists on the ideal timing, so these protocols have not yet been standardized to efficiently and safely return these pitchers to sport.
Furthermore, large, prospective studies must be designed to follow elite pitchers starting at the Little League level through their career. Although only a small percentage of these athletes will become MLB pitchers, it would be extremely valuable to see if implementing some of the rules and regulations aimed at decreasing elbow injuries were effective, and likewise to see if pitchers who did not adhere to the regulations were at higher risk for undergoing UCLR later in life. This would also give the orthopaedic community an idea if pitchers do in deed have a finite number of innings their body will allow them to pitch, thereby proving to coaches and parents the importance of limiting excessive pitching at early ages.
Recent times have seen an increase in the number of UCLR in MLB pitchers. While evidence has shown a greater than 80% RTS rate following UCLR, the RTS rate following revision UCLR is not as high. Further large scale, prospective studies are necessary to help dictate treatment algorithms in these high level athletes.
P- Reviewer: Angoules A, Guerado E, Metzger PD S- Editor: Gong XM L- Editor: A E- Editor: Li D